Fierce Pharma
NOVEMBER 21, 2023
With litigation spanning many countries, the COVID-19 vaccine giants remain engaged in a heated patent war. | Moderna pledged to appeal after the European Patent Office ruled one of its patents invalid in the intellectual property battle that spans multiple countries.
Pharmaceutical Technology
NOVEMBER 21, 2023
Texas AG has sued Pfizer and Tris Pharma for providing adulterated attention-deficit/hyperactivity disorder drug, Quillivant XR, to children.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
NOVEMBER 21, 2023
Texas has accused Pfizer and manufacturer Tris Pharma of knowingly providing compromised ADHD medicine to a state Medicaid program for children of low-income families. | In its lawsuit, Texas says the companies knew that deficient manufacturing processes compromised the effectiveness of Quillivant XR. The lawsuit further accuses the companies of manipulating quality-control testing from 2012 to 2018 to ensure samples received passing grades.
MedCity News
NOVEMBER 21, 2023
Merck’s acquisition of Caraway Therapeutics adds programs for genetically defined neurodegenerative diseases. One of those programs addresses a target that was the focus of a different startup purchased by Merck in 2019.
Fierce Pharma
NOVEMBER 21, 2023
Joining drugmakers like AstraZeneca and Novo Nordisk, GSK is making big strides in its quest to clean up its carbon footprint. | GSK plans to start late-stage trials of a low-carbon version of its metered dose inhaler (MDI) Ventolin utilizing a next-generation propellant in 2024. If the new product proves successful, it has the potential to slash greenhouse gas emissions from Ventolin use by roughly 90%.
MedCity News
NOVEMBER 21, 2023
RPM has ushered in a new era of healthcare. However, navigating the complexities and challenges of this landscape requires a thoughtful QA strategy.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
NOVEMBER 21, 2023
The DEA proposed a rule back in March that would roll back some of the Covid-19 flexibilities for the virtual prescribing of controlled substances, but has since extended the flexibilities. Stephanie Strong, founder and CEO of Boulder Care, feels confident that the DEA will continue to be open to the prescribing of these medications via telemedicine.
Fierce Pharma
NOVEMBER 21, 2023
After suffering setbacks in the clinic and in court over the last week, Bayer’s ability to overhaul its corporate structure is becoming more constricted, one group of analysts contends. | After suffering setbacks in the clinic and in court this week, Bayer’s ability to overhaul its corporate structure is becoming more constricted, one group of analysts contends.
European Pharmaceutical Review
NOVEMBER 21, 2023
Phase III trials of a low carbon version of GSK’s metered dose inhaler, Ventolin (salbutamol), using a next generation, lower carbon propellant, are set to start in 2024. The pharma company stated that if successful, it has the potential to reduce greenhouse gas emissions from use of the inhaler by approximately 90 percent. According to GSK, thirty-five million patients with respiratory conditions globally relying on its metered dose inhaler.
MedCity News
NOVEMBER 21, 2023
A California payer lays out the three things she wishes all entrepreneurs knew about how to bring their ideas to market most effectively and initiate successful collaboration.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Evolve Your Success
NOVEMBER 21, 2023
Success in medical sales is not only about knowledge, but also about the application of that knowledge, adapting proactively, and being aware of your impact in the room. In this episode, we have Rob Bahna discuss what truly makes a good medical sales rep. From his early beginnings to climbing the ladder of success, Rob provides a firsthand account of his journey through various leadership positions in medical sales.
MedCity News
NOVEMBER 21, 2023
At Northshore–Edward Elmhurst Health, all patients are offered genetic testing as part of their primary care visit. This helps clinicians create more personalized care plans and facilitates earlier disease diagnoses, said Kristen Murtos, the health system’s chief innovation and transformation officer.
European Pharmaceutical Review
NOVEMBER 21, 2023
BRUKINSA ® (zanubrutinib) in combination with the anti-CD20 monoclonal antibody obinutuzumab, has been approved by the European Commission (EC) to treat relapsed or refractory follicular lymphoma in individuals who have received at least two prior lines of systemic therapy. The oral treatment is now “the first Bruton’s tyrosine kinase (BTK) inhibitor approved in this indication and has the broadest label of any medicine in its class globally,” stated Dr Mehrdad Mobasher, Chief Medical Officer, H
MedCity News
NOVEMBER 21, 2023
Eating disorders don’t discriminate. Equip, a virtual company that provides eating disorder support, is trying to reach different populations by having a diverse care team and working with advisors from different backgrounds, said Kristina Saffran, CEO and co-founder of the company.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Pharmaceutical Technology
NOVEMBER 21, 2023
According to several key opinion leaders (KOLs) interviewed by GlobalData, pipeline gene therapy holds the greatest potential to transform the Gaucher disease landscape
MedCity News
NOVEMBER 21, 2023
BeiGene is expanding its cancer drug pipeline, landing global rights to an Ensem Therapeutics cancer drug candidate ready to enter the clinic. The drug targets CDK2, an enzyme whose excessive activity is associated with cancer progression.
PharmaTimes
NOVEMBER 21, 2023
SMPaeds2 aims to advance precision medicines for children with relapsed cancer - News - PharmaTimes
Pharmaceutical Technology
NOVEMBER 21, 2023
The FDA's decision on the sBLA for Abecma will be delayed beyond the set PDUFA target date of 16 December.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
PharmaTimes
NOVEMBER 21, 2023
Cerebral SVD contributes to 45% of dementia cases and 20% of ischaemic strokes - News - PharmaTimes
Pharmaceutical Technology
NOVEMBER 21, 2023
The new scheme will launch in 2024 and aims to save the National Health Service (NHS) £14bn over five years.
Pharmaceutical Commerce
NOVEMBER 21, 2023
IQVIA report explores why these shortages are increasing, and how they can be mitigated.
pharmaphorum
NOVEMBER 21, 2023
GSK says new inhaler will help slash its carbon footprint Phil.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Rep-Lite
NOVEMBER 21, 2023
Sales strategy consulting is a specialized form of management employed by a sales consulting firm that focuses on helping businesses improve their sales performance and achieve their revenue goals. So now that you have the gist of what sales strategy consulting is, let’s better understand what a sales consultant is. With over 30 years of experience in staffing medical and sales reps, clinical sales, and service positions, Rep-Lite can help you offload the burden of hiring sales professiona
Quantified
NOVEMBER 21, 2023
In today’s ever-changing sales environment, professional coaching has risen to become a core need across industries. For organizations, better-coached employees lead to improved performance and productivity that drives a strong ROI. Meanwhile, workers across all skill levels now expect regular coaching from their employers. Rapid advancements in technology, market trends, and customer expectations require workers to continuously adapt and enhance their skills.
pharmaphorum
NOVEMBER 21, 2023
MSD reaches $610m deal to buy lysosome biotech Caraway Phil.
Pharmacy Times
NOVEMBER 21, 2023
Christian John Lillis, co-founder and executive director at Peggy Lillis Foundation, discusses the role of the pharmacist in education that advances C diff awareness in the medical community.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
pharmaphorum
NOVEMBER 21, 2023
MorphoSys shrugs off mixed results for myelofibrosis drug Phil.
Pharmacy Times
NOVEMBER 21, 2023
Zavegepant (Zavzpret; Pfizer) is the first and only only CGRP receptor antagonist as a nasal spray for the acute treatment of migraine in adults with and without aura approved by the FDA.
Pharmaceutical Technology
NOVEMBER 21, 2023
Ensem will receive an upfront payment and will be eligible for additional payments upon the achievement of milestones, totalling up to $1.33bn.
Pharmacy Times
NOVEMBER 21, 2023
Paul Feuerstadt, MD, FACG, AGAF, discusses insights in current treatment practices for CDI at the Peggy Lillis Foundation’s 2023 State of C diff Virtual Town Hall.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Expert insights. Personalized for you.
357 
Let's personalize your content